Case Report: Intravenous transplantation of autologous adipose tissue-derived mesenchymal stem cells attenuated atopic dermatitis

• by Kosuke Mabuchi, Yoshie Takahashi, Yuka Okinaka, Kana Nagase, Yosky Kataoka, Akihiko Taguchi

• May 4, 2026

Efficacy and safety of upadacitinib in treating immune drift: a single-center, prospective study in China

• by Wanyan Xiang, Jiarong Lu, Siqi Zhang, Wenjun Zheng, Qiuju Li

• July 6, 2026

Divergent immunometabolic reprogramming in psoriasis and atopic dermatitis: a tale of two inflammatory skin diseases

• by Nan Chen, Yehong Yue, Liang Zhou

• July 16, 2026

FDA Approves Less Frequent Lebrikizumab Dosing

Approval adds an every-8-week maintenance option for eligible patients with moderate-to-severe atopic dermatitis.

• by Kathryn Wighton

• June 10, 2026

• 2 min